• Home
  • Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.

Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer.

Author List
Gartrell BA, Roach M, Retter A, Sokol GH, Del Priore G, Scher HI
Publication
Investigational new drugs
Publication ID (Profile URL)
https://researcherprofiles.org/profile/138658736
Publication Year
2020
PubMed ID
32924093
Publication Title
Gartrell BA, Roach M, Retter A, Sokol GH, Del Priore G, Scher HI. Phase II trial of SM-88, a cancer metabolism based therapy, in non-metastatic biochemical recurrent prostate cancer. Invest New Drugs. 2021 04; 39(2):499-508.